The Technical Analyst
Semler Scientific, Inc. [SMLR]
Exchange: PNK Industry: Medical Devices
Semler Scientific, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
0.77% $26.11
America/New_York / 26 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 183.58 mill |
| EPS: | 2.63 |
| P/E: | 9.93 |
| Earnings Date: | May 07, 2024 |
| SharesOutstanding: | 7.03 mill |
| Avg Daily Volume: | 0.0781 mill |
| RATING 2024-04-26 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 9.93 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 9.93 | industry: PE -6.92 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$75.18 (187.92%) $49.07 |
| Date: 2024-04-26 |
| Expected Trading Range (DAY) |
|---|
|
$ 24.26 - 27.97 ( +/- 7.10%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-09-13 | Semler Eric | Buy | 26 868 | Common Stock, $0.001 par value |
| 2023-09-12 | Semler Eric | Buy | 25 903 | Common Stock, $0.001 par value |
| 2023-09-11 | Semler Eric | Buy | 25 000 | Common Stock, $0.001 par value |
| 2023-07-10 | Cormier Renae | Buy | 5 000 | Stock Option (right to buy) |
| 2023-07-10 | Cormier Renae | Sell | 5 000 | Stock Option (right to buy) |
| INSIDER POWER |
|---|
| 16.16 |
| Last 99 transactions |
| Buy: 115 420 | Sell: 125 271 |
Forecast:
16:00 - $26.05
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $26.05
Forecast 2: 16:00 - $26.05
Forecast 3: 16:00 - $26.05
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $26.11 (0.77% ) |
| Volume | 0.0300 mill |
| Avg. Vol. | 0.0781 mill |
| % of Avg. Vol | 38.41 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SMLR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:34 | sell | $47.86 | N/A | Active |
|---|
SMLR
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Latest Press Releases
2024-04-23 08:03:00 - Press Release
Semler Scientific To Report First Quarter Financial Results And Host Conference Call On May 7, 2024
Santa clara, calif. , april 23, 2024 /prnewswire/ -- semler scientific, inc. (nasdaq: smlr), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter ended march 31, 2024, after the close of u.s. financial markets on tuesday, may 7, 2024.
2024-03-05 16:01:00 - Press Release
Semler Scientific Reports Fourth Quarter And Full Year 2023 Financial Results
2023 q4 and full year highlights compared to the corresponding period of 2022: fourth quarter revenues were $15.1 million, an increase of 9% fourth quarter net income was $4.2 million, an increase of 31% full year revenues were $68.2 million, an increase of 20% full year net income was $20.6 million, an increase of 44% cash balance increased to $57.3 million santa clara, calif. , march 5, 2024 /prnewswire/ -- semler scientific, inc. (nasdaq: smlr), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today reported financial results for the fourth quarter and full year ended december 31, 2023.
2024-02-21 08:03:00 - Press Release
Semler Scientific To Report Fourth Quarter And Year End 2023 Financial Results And Host Conference Call On March 5, 2024
Santa clara, calif. , feb. 21, 2024 /prnewswire/ -- semler scientific, inc. (nasdaq: smlr), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the fourth quarter and full year ended december 31, 2023, after the close of u.s. financial markets on tuesday, march 5, 2024.
2023-10-26 16:01:00 - Press Release
Semler Scientific To Report Third Quarter And First Nine Months Of 2023 Financial Results And Host Conference Call On November 9, 2023
Santa clara, calif. , oct. 26, 2023 /prnewswire/ -- semler scientific, inc. (nasdaq: smlr), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the third quarter and first nine months ended september 30, 2023, after the close of u.s. financial markets on thursday, november 9, 2023.
2023-08-31 16:01:00 - Press Release
Semler Scientific To Present At Upcoming Investor Conference
Santa clara, calif. , aug. 31, 2023 /prnewswire/ -- semler scientific, inc. (nasdaq: smlr), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced renae cormier, cfo, will participate in the following investor conference: lake street capital markets 7th annual best ideas growth (big7) conference date: september 14, 2023 format: one-on-one meetings about semler scientific, inc.: semler scientific, inc. develops, manufactures and markets innovative products and services that assist in evaluating and treating chronic diseases.
Latest News
2024-04-23 08:03:00 - PRNewsWire
Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
SANTA CLARA, Calif. , April 23, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of U.S. financial markets on Tuesday, May 7, 2024.
2024-03-27 13:57:50 - InvestorPlace
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
With the market trading near all-time highs, undervalued healthcare stocks offer a compelling opportunity. Fundamentally, the sector could benefit from a rotation in the innovation ecosystem.
2024-02-21 08:03:00 - PRNewsWire
Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024
SANTA CLARA, Calif. , Feb. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023, after the close of U.S. financial markets on Tuesday, March 5, 2024.
2023-11-27 15:02:05 - InvestorPlace
3 Millionaire-Maker Tech Stocks That Could Soar Over 1,000%
The recent sell-off in tech stocks has left many high-quality names trading at sizable discounts. For long-term investors, this presents an intriguing opportunity to position one's portfolio for the next bull market.
2023-11-09 19:38:05 - Seeking Alpha
Semler Scientific, Inc. (SMLR) Q3 2023 Earnings Call Transcript
Semler Scientific, Inc. (NASDAQ:SMLR ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Doug Murphy-Chutorian – Chief Executive Officer Renae Cormier – Chief Financial Officer Jennifer Oliva Herrington – Chief Operating Officer Conference Call Participants Aaron Wukmir – Lake Street Capital Markets Herbert Semler – Semler Health Operator Good afternoon, and welcome to the Semler Scientific 2023 Third Quarter Financial Results Conference Call. All participants will be in a listen-only mode.
2023-09-26 04:29:39 - Seeking Alpha
Semler Scientific: The Business Is So Stellar That I'm Willing To Overlook Yellow Flags
Semler Scientific's 1H 2023 was surprisingly strong, with record high fixed-fee and variable-fee revenues. Semler's strong financial performance stands in stark contrast to its stock price, which has languished at a price even below where it was during the pandemic. Short-term, the market is concerned that the Hierarchical Condition Categories (HCC) codes effective in 2024 will reimburse QuantaFlo at a lower clip than in previous years.
2023-08-31 16:01:00 - PRNewsWire
Semler Scientific to Present at Upcoming Investor Conference
SANTA CLARA, Calif. , Aug. 31, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced Renae Cormier, CFO, will participate in the following investor conference: Lake Street Capital Markets 7th Annual Best Ideas Growth (BIG7) Conference Date: September 14, 2023 Format: One-on-one meetings About Semler Scientific, Inc.: Semler Scientific, Inc. develops, manufactures and markets innovative products and services that assist in evaluating and treating chronic diseases.
2023-08-10 23:36:08 - Seeking Alpha
Semler Scientific, Inc. (SMLR) Q2 2023 Earnings Call Transcript
Start Time: 16:30 January 1, 0000 4:49 PM ET Semler Scientific, Inc. (NASDAQ:SMLR ) Q2 2023 Earnings Conference Call August 10, 2023, 16:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO Renae Cormier - CFO Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Good afternoon, and welcome to the Semler Scientific 2023 Second Quarter Financial Results Conference Call. All participants will be in a listen-only mode.
2023-07-28 08:03:00 - PRNewsWire
Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023
SANTA CLARA, Calif. , July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the second quarter ended June 30, 2023, after the close of U.S. financial markets on Thursday, August 10, 2023.
2023-05-10 20:44:17 - Seeking Alpha
Semler Scientific, Inc. (SMLR) Q1 2023 Earnings Call Transcript
Semler Scientific, Inc. (NASDAQ:SMLR ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Douglas Murphy-Chutorian - Interim Chief Executive Officer Renae Cormier - Head of Corporate Communications and Business Strategy Andrew Weinstein - Senior Vice President, Finance and Accounting Dennis Rosenberg - Chief Marketing Officer Conference Call Participants Operator Good afternoon, and welcome to the Semler Scientific 2023 First Quarter Financial Results Conference Call. All participants will be in a listen-only mode.